2.3. Exposure
The exposure in this study was a CDSS for nonvalve AF anticoagulation management, which was developed by our team and Ping An Healthcare and Technology Co., Ltd., Beijing, China. The decision-making processes of the CDSS were developed based on the latest AF guidelines in China at that time [